Back to results

Active, not recruitingPhase 2

A Study to Evaluate the Effects of ACI-7104.056 in Patients With Early Stages of Parkinson's Disease

NCT06015841

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Katholisches Klinikum Bochum GmbH

Bochum, Germany

+11 additional locations

View on ClinicalTrials.gov

Save this trial

Quick facts

Start date: 2023-07-24
Enrollment: 150 participants
Sponsor: AC Immune SA
Purpose: treatment

Locations (12)

Katholisches Klinikum Bochum GmbHBochum, Germany
Paracelsus-Kliniken Deutschland GmbH & Co. KGaAKassel, Germany
University Medical Centre Schleswig-HolsteinKiel, Germany
Hospital De La Santa Creu I Sant PauBarcelona, Spain
Hospital Universitari Vall D HebronBarcelona, Spain
Policlinica GipuzkoaDonostia / San Sebastian, Spain
Hospital Universitario De La PrincesaMadrid, Spain
Hospital Universitario Puerta De Hierro De MajadahondaMajadahonda, Spain
Hospital Universitario Quironsalud MadridPozuelo de Alarcón, Spain
King's College Hospital NHS Foundation TrustLondon, United Kingdom
Re:Cognition Health LimitedLondon, United Kingdom
Northern Care Alliance NHS Foundation TrustSalford, United Kingdom

A Study to Evaluate the Effects of ACI-7104.056 in Patients With Early Stages of Parkinson's Disease — TrialFind